SCHEMBL5014934

SCHEMBL5014934

O=C(O)CCNCCCNCCC(=O)O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.47
SLC22A6 Q4U2R8 1/20 0.47
TSHR P16473 2/20 0.45
NFKB1 P19838 1/20 0.45
PMP22 Q01453 1/20 0.45
LTA4H P09960 2/20 0.44
ALKBH5 Q6P6C2 1/20 0.44
SUCNR1 Q9BXA5 1/20 0.44
EGLN1 Q9GZT9 1/20 0.44
S1PR1 P21453 4/20 0.43
S1PR3 Q99500 2/20 0.43
PRMT1 Q99873 1/20 0.42
S1PR5 Q9H228 1/20 0.41
CAMK2A Q9UQM7 1/20 0.41
ECE1 P42892 1/20 0.41
CA3 P07451 2/20 0.39
CA5A P35218 2/20 0.39
CA5B Q9Y2D0 2/20 0.39
ADRA1A P35348 1/20 0.39
CA12 O43570 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12935681 0.94 PRMT1 (0.48) LMNASLC22A6TSHRNFKB1PMP22
SCHEMBL5022764 0.92 LTA4H (0.41) LMNASLC22A6TSHRNFKB1PMP22
SCHEMBL7389117 0.92 LMNA (0.53) LMNASLC22A6TSHRNFKB1PMP22
SCHEMBL30407212 0.92 PRMT1 (0.46) LMNASLC22A6TSHRNFKB1PMP22
SCHEMBL2804324 0.92 PRMT1 (0.52) LMNASLC22A6TSHRNFKB1PMP22
SCHEMBL109879 0.91 LMNA (0.53) LMNASLC22A6TSHRNFKB1PMP22
SCHEMBL31370221 0.88 KDM4A (0.46) LMNASLC22A6TSHRNFKB1PMP22
SCHEMBL17433002 0.88 LMNA (0.50) LMNASLC22A6TSHRNFKB1PMP22
SCHEMBL5035377 0.88 LMNA (0.50) LMNASLC22A6TSHRNFKB1PMP22
SCHEMBL162041 0.88 LMNA (0.50) LMNASLC22A6TSHRNFKB1PMP22

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119350177-A Preparation method of carboxyl-terminated dinitramine compound 西安近代化学研究所 2025-01-24 CN disclosed
US-10023530-B2 Diamine, polyamic acid, and polyimide NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2018-07-17 US disclosed
US-20160264520-A1 NOVEL DIAMINE, POLYAMIC ACID, AND POLYIMIDE NISSAN CHEMICAL INDUSTRIES. LTD. (JP) 2016-09-15 US disclosed
US-20080115423-A1 Polishing Composition For Silicon Wafer NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2008-05-22 US disclosed
EP-0509149-B1 Thermal dye sublimation transfer receiving element AGFA GEVAERT NV (BE) 1996-03-13 EP disclosed
US-5284815-A Image-receiving layer containing an isocyanate-based polymer having a crosslinked and cured surface; dyeability; releasability from the dye donor element AGFA-GEVAERT, N.V. (BE) 1994-02-08 US disclosed
EP-0509149-A1 Thermal dye sublimation transfer receiving element AGFA-GEVAERT N.V. (BE) 1992-10-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10023530-B2 Diamine, polyamic acid, and polyimide H1-2, H1-4, H1-0 LMNA 746/4885SLC22A6 3167/4885TSHR 2393/4885
US-20160264520-A1 NOVEL DIAMINE, POLYAMIC ACID, AND POLYIMIDE H1-4, H1-2, H1-5 LMNA 1011/4885SLC22A6 2957/4885TSHR 3020/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.